Concentra amends report on 1M-share insider sale
Rhea-AI Filing Summary
Concentra Group Holdings Parent, Inc. (CON) reported that director Robert A. Ortenzio and related trusts disposed of common stock to the company on August 21, 2026, in transactions already previously reported. The amendment corrects administrative errors and adds an omitted indirect holding, without introducing new transactions. Under a Stock Repurchase Agreement, the company agreed to repurchase an aggregate of 1,000,000 shares at $34.65 per share, including 770,000 shares held directly by Ortenzio and 230,000 shares held through trusts for his descendants. After these dispositions, Ortenzio directly holds 4,663,794 shares, with additional indirect holdings through several family trusts, including 882,115 shares in the Descendants Trust and 196,286 or 206,286 shares in each of several 2014 trusts. A separate 503,455-share indirect holding in the Rocco A. Ortenzio Separate Descendants Trust was also reported as a holding entry, with no change in beneficial ownership. The Audit Committee of the board, consisting solely of Non-Employee Directors, approved the dispositions for exemption under Rule 16b-3(e).
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock F1, F2, F3 | 770,000 | $34.65 | $26.68M |
| Disposition | Common Stock F1, F2, F4 | 150,000 | $34.65 | $5.20M |
| Disposition | Common Stock F1, F2, F5 | 30,000 | $34.65 | $1.04M |
| Disposition | Common Stock F1, F2, F6 | 30,000 | $34.65 | $1.04M |
| Disposition | Common Stock F1, F2, F7 | 20,000 | $34.65 | $693K |
| holding | Common Stock F8 | -- | -- | -- |
Footnotes (8)
- F1. The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee.
- F2. The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder.
- F3. The total number of securities reported has been updated to correct an administrative error.
- F4. 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
- F5. 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
- F6. 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
- F7. 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
- F8. These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred.
Key Figures
Key Terms
Stock Repurchase Agreement financial
Section 16(b) regulatory
Rule 16b-3(e) regulatory
Non-Employee Directors regulatory
beneficial ownership financial
FAQ
What insider transactions did CON report for Robert A. Ortenzio on August 21, 2026?
Is this amended Form 4/A for CON reporting new insider transactions?
Were the CON insider dispositions approved under Rule 16b-3?
What previously omitted CON holding was added in this amended Form 4/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.